ArticleFrontiers in endocrinology2025
Machine learning-based quantification of overall and internal ultrasound characteristics for diagnosing malignant partially cystic thyroid nodules.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Partially cystic thyroid nodules (PCTNs) with malignant potential are frequently underestimated due to limited recognition of their sonographic characteristics. Methods: This retrospective analysis included 486 PCTNs identified between March 2021 and September 2022. Machine learning (ML) was employed to quantitatively evaluate the overall ultrasound characteristics of the whole nodule as well as the internal ultrasound characteristics of its solid part. Three diagnostic models were constructed based on different sets of ultrasound data. The dataset was split into training and testing subsets at a 7:3 ratio. Key ultrasound characteristics such as marked hypoechogenicity, calcifications, solid component≥50%, and unclear internal margins were emphasized. Results: Among the models, the integrated one- incorporating both overall-nodule and internal solid-part characteristics-achieved superior diagnostic performance, with an area under the curve (AUC) of 0.96 (0.93-0.99) on the test data. The model demonstrated an accuracy of 0.91 (0.85-0.95), a sensitivity of 0.88 (0.73-0.97), a specificity of 0.92 (0.85-0.96), a negative predictive value of 0.96 (0.91-0.99), and a positive predictive value of 0.77 (0.61-0.89). This comprehensive model significantly outperformed the model utilizing only overall nodule characteristics (AUC = 0.85, P = 2.35e-6), and demonstrated comparable effectiveness to the model based solely on internal characteristics (AUC = 0.93, P = 1.01e-1). Discussion: The results support the clinical utility of an ML-driven approach that integrates comprehensive ultrasound metrics for the reliable identification of malignant PCTNs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.